IGF2BP3 and plasma cell myeloma: The Oncomine database was used to determine the expression level of IGF2BP3. And as shown in Fig. 7D, IGF2BP3 in most cancer types showed high expression levels, except for kidney cancer and myeloma, which were opposite to the TCGA database.